Skip to main content

Table 2 Univariate analysis for all demographic and clinical variables pertinent to diagnosis of acute HF or pulmonary disease (N = 218)a

From: Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting

Variablesb

Pulmonary-related dyspnea (n= 89)

Acute HF-related dyspnea (n= 129)

P valuec

Mean age, yr (± SD)

52.3 ± 15.3

70.9 ± 11.7

0.001

Sex, males/females (%)

176/87 (67%)

1,158/421 (73%)

0.74

Nocturnal dyspnea, Y/N

6/83

1/2

< 0.001

Orthopnea, Y/N

7/82

13/30

< 0.001

Cough, Y/N

17/41

34/95

< 0.001

Sputum production, Y/N

24/65

8/121

< 0.001

Fever, Y/N

21/68

7/122

< 0.001

Murmur, Y/N

8/81

29/100

< 0.001

Rales, Y/N

10/79

217/53

< 0.001

Wheezes, Y/N

12/3

47/82

< 0.001

Mean pulse rate, beats/min (± SD)

115.7 ± 14.1

106.3 ± 12.8

0.564

Jugular venous distension, Y/N

3/86

10/33

< 0.001

Lower extremity edema, Y/N

12/77

62/67

< 0.001

ECG-normal sinus rhythm, Y/N

210/17

55/72

< 0.001

Asthma/COPD medications, Y/N

65/11

13/116

< 0.001

HF medications, Y/N

33/56

245/46

< 0.001

Troponin T > 0.03 ng/mL, Y/N

8/81

49/80

< 0.001

Mean petCO2, kPa (± SD)

6.9 ± 1.6

3.6 ± 1.1

0.01

Mean NT-proBNP, pg/mL (± SD)

598.2 ± 361.8

2,263 ± 641.2

0.008

Mean SaO2, % (± SD)

75.7 ± 10.1

67.9 ± 12.8

0.76

Ultrasound examination-positive, Y/N

5/84

129/0

< 0.001

Previous arrhythmia, Y/N

7/82

52/77

< 0.001

Previous AMI, Y/N

7/82

15/28

< 0.001

Previous CHF, Y/N

17/72

233/49

< 0.001

Previous asthma/COPD, Y/N

169/19

9/34

< 0.001

ETI, Y/N

3/86

10/119

< 0.001

Mean modified Boston criteria score for diagnosing HFd (± SD)

4.6 ± 1.2

10.9 ± 1.8

< 0.001

  1. aY, yes; N, no; petCO2, partial pressure of end-tidal carbon dioxide; NT-proBNP, amino terminal pro-brain natriuretic peptide; ECG, electrocardiogram; HF, heart failure; CHF, congestive heart failure; AMI, acute myocardial infarction; SaO2, arterial oxygen saturation; ETI, endotracheal intubation; COPD, chronic obstructive pulmonary disease. bResults are presented as means ± standard deviation for normally distributed data or ratio or percentage for other variables. cUnivariate comparison was made using the χ2 test for categorical variables and a t-test for continuous variables. For evaluation of diagnostic accuracy, patients were divided into two groups: HF-related acute dyspnea and pulmonary-related acute dyspnea (COPD/asthma). dModified Boston criteria according to Table 1 and Remes et al. [6].